These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 26231605)

  • 21. Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis.
    Chang TS; Wu YC; Tung SY; Wei KL; Hsieh YY; Huang HC; Chen WM; Shen CH; Lu CH; Wu CS; Tsai YH; Huang YH
    Am J Gastroenterol; 2015 Jun; 110(6):836-44; quiz 845. PubMed ID: 25869392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and Experimental Evaluation of Diagnostic Significance of Alpha-Fetoprotein and Osteopontin at the Early Stage of Hepatocellular Cancer.
    Macek-Jilkova Z; Malov SI; Kurma K; Charrat C; Decaens T; Peretolchina NP; Marche PN; Malov IV; Yushchuk ND
    Bull Exp Biol Med; 2021 Jan; 170(3):340-344. PubMed ID: 33452981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of β-catenin protein in hepatocellular carcinoma and its relationship with alpha-fetoprotein.
    Ren YJ; Huang T; Yu HL; Zhang L; He QJ; Xiong ZF; Peng H
    J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):846-851. PubMed ID: 27924522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatocellular Carcinoma Surveillance: Does Alpha-Fetoprotein Have a Role?
    Mehta A; Singal AG
    Gastroenterology; 2015 Sep; 149(3):816-7. PubMed ID: 26231605
    [No Abstract]   [Full Text] [Related]  

  • 25. Biomarkers for the early diagnosis of hepatocellular carcinoma.
    Tsuchiya N; Sawada Y; Endo I; Saito K; Uemura Y; Nakatsura T
    World J Gastroenterol; 2015 Oct; 21(37):10573-83. PubMed ID: 26457017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New perspectives and strategy research biomarkers for hepatocellular carcinoma.
    Saffroy R; Pham P; Reffas M; Takka M; Lemoine A; Debuire B
    Clin Chem Lab Med; 2007; 45(9):1169-79. PubMed ID: 17635075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer biomarkers for hepatocellular carcinomas: from traditional markers to recent topics.
    Masuda T; Miyoshi E
    Clin Chem Lab Med; 2011 Jun; 49(6):959-66. PubMed ID: 21428856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surveillance for hepatocellular carcinoma.
    Sherman M
    Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):783-93. PubMed ID: 25260308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha-foetoprotein (AFP): A multi-purpose marker in hepatocellular carcinoma.
    Sauzay C; Petit A; Bourgeois AM; Barbare JC; Chauffert B; Galmiche A; Houessinon A
    Clin Chim Acta; 2016 Dec; 463():39-44. PubMed ID: 27732875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma.
    Song PP; Xia JF; Inagaki Y; Hasegawa K; Sakamoto Y; Kokudo N; Tang W
    World J Gastroenterol; 2016 Jan; 22(1):262-74. PubMed ID: 26755875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver Cancer in Tyrosinemia Type 1.
    van Ginkel WG; Pennings JP; van Spronsen FJ
    Adv Exp Med Biol; 2017; 959():101-109. PubMed ID: 28755188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prominence of potential biomarkers in the diagnosis and management of hepatocellular carcinoma: Current scenario and future anticipation.
    Mir IH; Jyothi KC; Thirunavukkarasu C
    J Cell Biochem; 2022 Oct; 123(10):1607-1623. PubMed ID: 34897788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The immunosuppression role of alpha-fetoprotein in human hepatocellular carcinoma.
    Meng W; Bai B; Bai Z; Li Y; Yue P; Li X; Qiao L
    Discov Med; 2016 Jun; 21(118):489-94. PubMed ID: 27448785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders.
    Wong RJ; Ahmed A; Gish RG
    Clin Liver Dis; 2015 May; 19(2):309-23. PubMed ID: 25921665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Alpha-fetoprotein producing hepatocellular carcinoma, AT-III producing hepatocellular carcinoma].
    Nakamura K; Makino I
    Ryoikibetsu Shokogun Shirizu; 1995; (7):265-8. PubMed ID: 8749467
    [No Abstract]   [Full Text] [Related]  

  • 36. Alpha-fetoprotein: a renaissance.
    Terentiev AA; Moldogazieva NT
    Tumour Biol; 2013 Aug; 34(4):2075-91. PubMed ID: 23765762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Alpha-Fetoprotein in the Pathogenesis of Cancer.
    Chaudhuri AG; Samanta S; Dey M; Raviraja NS; Dey S
    J Environ Pathol Toxicol Oncol; 2024; 43(2):57-76. PubMed ID: 38505913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbohydrate metabolism in hepatocellular carcinoma: where does the glucose go?
    Marchesini G; Bianchi G
    Hepatology; 1989 Aug; 10(2):253-5. PubMed ID: 2545591
    [No Abstract]   [Full Text] [Related]  

  • 39. Alpha-fetoprotein, stem cells and cancer: how study of the production of alpha-fetoprotein during chemical hepatocarcinogenesis led to reaffirmation of the stem cell theory of cancer.
    Sell S
    Tumour Biol; 2008; 29(3):161-80. PubMed ID: 18612221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Research advances in the role of CX3CL1 and its receptor in liver diseases].
    Zhang P; He SS; Tong QX
    Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):313-6. PubMed ID: 27470635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.